TABLET FORMULATION CONTAINING SALT OF 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE, AND TABLET PREPARED FROM THE SAME
PROBLEM TO BE SOLVED: To provide a tablet formulation containing the salt of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one, and a tablet prepared from the same.SOLUTION: There are disclosed a medicinal formulation suitable for forming a tablet type dosage form, which contains the salt of (5S,8S)-8-[{(1R)-1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one represented by the formula I, and the tablet type dosage form. Also, there is disclosed a method of treatment using the dosage form.【課題】8-[{1-(3,5-ビス-(トリフルオロメチル)フェニル)-エトキシ}-メチル]-8-フェニル-1,7-ジアザ-スピロ[4.5]デカン-2-オンの塩を含む錠剤処方物およびそれから作製される錠剤の提供。【解決手段】錠剤型剤形を形成させるのに適した、式Iで表される(5S,8S)-8-[{(1R)-1-(3,5-ビス-(トリフルオロメチル)フェニル)-エトキシ}-メチル]-8-フェニル-1,7-ジアザスピロ[4.5]デカン-2-オンの塩を含む医薬処方物、ならびにその錠剤型剤形を開示する。そうした剤形を用いた治療方法も開示する。【選択図】なし